Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori outer-membrane and surface antigens are a diverse array of proteins and lipopolysaccharides that reside on the bacterial surface. These molecules are critical for the pathogen's ability to survive the acidic environment of the stomach and colonize the gastric mucosa. Key components include adhesins like Blood group antigen-binding adhesin (BabA), which facilitate high-affinity binding to host cells (PubMed: 9488644). They also include porins and transport proteins that manage nutrient uptake and the secretion of virulence factors such as Vacuolating cytotoxin A (VacA) (PubMed: 23022316). As the primary interface with the host, these antigens are the focus of diagnostic assays, such as the stool antigen test used in clinical practice (StatPearls: NBK544250). In therapeutic development, these surface proteins are targeted by experimental vaccines designed to induce mucosal immunity and prevent bacterial attachment (PubMed: 30254321). Some drugs, like bismuth-based compounds, interact with these surface structures to exert antimicrobial effects and disrupt biofilm formation. Understanding the variability of these antigens is essential for overcoming challenges related to strain diversity and immune evasion in H. pylori infections.
Neutralization of bacterial toxins and inhibition of bacterial adhesion to the gastric mucosa (PubMed: 30254321).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori outer-membrane and surface antigens (H. pylori OMPs).